Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 21.02 is in line with its 5-year average of 22.94, near the low end of its 5-year range (12.52–68.36).
As of the fiscal period ended Tuesday, June 30, 2026. 16.90% above its 12-month average of 17.98.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 21.02.
CURRENT RATIO
21.02
CURRENT RATIO AVG TTM
17.98
CURRENT RATIO AVG 3Y
19.61
CURRENT RATIO AVG 5Y
22.94
CURRENT RATIO AVG 10Y
18.36
CURRENT RATIO AVG 15Y
15.45
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+16.90%
CURRENT VS 3Y AVG
+7.16%
CURRENT VS 5Y AVG
-8.39%
CURRENT VS 10Y AVG
+14.46%
CURRENT VS 15Y AVG
+36.06%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+458.91%
vs the sector median at left
Xenon Pharmaceuticals Inc.
Market Cap
$3.54B
Current Ratio
21.02
TTM Avg
17.98
3Y Avg
19.61
5Y Avg
22.94
Market Cap
$3.52B
Current Ratio
3.87
TTM Avg
5.22
3Y Avg
3.96
5Y Avg
4.18
Market Cap
$3.57B
Current Ratio
50.82
TTM Avg
11.65
3Y Avg
9.40
5Y Avg
9.07
Market Cap
$3.48B
Current Ratio
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
Market Cap
$3.64B
Current Ratio
1.42
TTM Avg
24.66
3Y Avg
24.23
5Y Avg
16.18
Market Cap
$3.38B
Current Ratio
3.39
TTM Avg
3.10
3Y Avg
3.17
5Y Avg
4.31
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | $3.54B | 21.02 | 17.98 | 19.61 | 22.94 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 3.87 | 5.22 | 3.96 | 4.18 |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 9.16 | 6.44 | 5.38 | 7.95 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | 50.82 | 11.65 | 9.40 | 9.07 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 9.63 | 11.21 | 9.89 | 7.80 |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.64B | 1.42 | 24.66 | 24.23 | 16.18 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 3.39 | 3.10 | 3.17 | 4.31 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 17.91 | 1.68 | 1.68 | 1.68 |
Current Ratio
21.02
Quick Ratio
21.02
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 21.02 |
| 2026-03-31 | 27.79 |
| 2025-12-31 | 13.42 |
| 2025-09-30 | 12.52 |
| 2025-06-30 | 15.14 |
| 2025-03-31 | 17.66 |
| 2024-12-31 | 17.85 |
| 2024-09-30 | 22.21 |
| 2024-06-30 | 23.27 |
| 2024-03-31 | 31.82 |
| 2023-12-31 | 23.65 |
| 2023-09-30 | 21.46 |
| 2023-06-30 | 19.34 |
| 2023-03-31 | 23.71 |
| 2022-12-31 | 26.44 |
| 2022-09-30 | 41.78 |
| 2022-06-30 | 57.86 |
| 2022-03-31 | 68.36 |
| 2021-12-31 | 39.03 |
| 2021-09-30 | 19.94 |
| 2021-06-30 | 17.81 |
| 2021-03-31 | 24.65 |
| 2020-12-31 | 12.30 |
| 2020-09-30 | 11.52 |
| 2020-06-30 | 9.83 |
| 2020-03-31 | 4.82 |
| 2019-12-31 | 3.34 |
| 2019-09-30 | 8.25 |
| 2019-06-30 | 11.07 |
| 2019-03-31 | 17.57 |
| 2018-12-31 | 29.48 |
| 2018-09-30 | 29.34 |
| 2018-06-30 | 20.80 |
| 2018-03-31 | 9.68 |
| 2017-12-31 | 10.98 |
| 2017-09-30 | 14.71 |
| 2017-06-30 | 13.95 |
| 2017-03-31 | 16.47 |
| 2016-12-31 | 18.68 |
| 2016-09-30 | 17.95 |
| 2016-06-30 | 18.23 |
| 2016-03-31 | 20.29 |
| 2015-12-31 | 21.88 |
| 2015-09-30 | 12.39 |
| 2015-06-30 | 6.19 |
| 2015-03-31 | 7.51 |
| 2014-12-31 | 5.95 |
| 2014-09-30 | 2.95 |
| 2014-06-30 | 2.62 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 2.74 |
| 2013-09-30 | 0.00 |
| 2013-06-30 | 2.86 |
| 2013-03-31 | 2.86 |
| 2012-12-31 | 3.16 |
| 2012-09-30 | 3.16 |
